Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

Recent studies are helping researchers better understand the power of the mind-body connection in treating hot flashes.

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...